C07J 1/007
The substituent being an oh group free esterified or etherified
Official title: {the substituent being an OH group free esterified or etherified}
C07J1/007 (The substituent being an oh group free esterified or etherified) appears on 214 US grants and 140 published applications in this corpus.
Search patents in C07J- Granted patents
- 214
- Published applications
- 140
- Assignees
- 137
- Inventors
- 440
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 9 | 0 |
| 1978 | 8 | 0 |
| 1979 | 0 | 0 |
| 1980 | 8 | 0 |
| 1981 | 8 | 0 |
| 1982 | 8 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 5 | 8 |
| 2003 | 4 | 9 |
| 2004 | 6 | 10 |
| 2005 | 3 | 7 |
| 2006 | 5 | 7 |
| 2007 | 4 | 1 |
| 2008 | 3 | 4 |
| 2009 | 1 | 4 |
| 2010 | 2 | 5 |
| 2011 | 2 | 4 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 0 | 6 |
| 2015 | 3 | 7 |
| 2016 | 5 | 11 |
| 2017 | 3 | 8 |
| 2018 | 6 | 7 |
| 2019 | 8 | 7 |
| 2020 | 5 | 4 |
| 2021 | 3 | 5 |
| 2022 | 6 | 4 |
| 2023 | 3 | 6 |
| 2024 | 1 | 6 |
| 2025 | 3 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 2-methoxyestradiol derivatives and medical uses thereof10 Mar 2026US 12,570,685 B2Institut Pasteur Korea
- Process for the preparation of trenbolone and/or trenbolone acetate4 Nov 2025US 12,459,969 B2F.I.S. - Fabbrica Italiana Sintetici S.p. A.
- Intermediates for the preparation of 11-methylene steroids18 Feb 2025US 12,227,537 B2Crystal Pharma, S.A.U.
- 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof21 Jan 2025US 12,201,640 B2Sage Therapeutics, Inc.
- 19-nor neuroactive steroids and methods of use thereof27 Feb 2024US 11,912,737 B2Sage Therpeutics, Inc.
- Process For The Purification Of 2-Methoxyestradiol From 4- Methoxyestradiol And Intermediates Of The Process24 Sep 2026US 2026/0285896 A1Industriale Chimica S.R.L.
- Estradiol prodrugs and methods of use thereof27 Aug 2026US 2026/0248809 A1The United States Government as represented by the Department of Veterans Affairs
- Process for preparing (15alpha,16alpha,17beta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol (estetrol) and intermediates of said process4 Jun 2026US 2026/0152523 A1Industriale Chimica S.R.L.
- 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof16 Oct 2025US 2025/0319106 A1Sage Therapeutics, Inc.
- Process for the production of estetrol intermediates9 Oct 2025US 2025/0313592 A1Estetra Srl
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- Estrogenic compounds as anti-angiogenic agents112US 5,504,074 AChildren's Medical Center Corporation · 1996
- Pharmaceutical preparation adapted for oral administration85US 4,071,623 AAkzona Incorporated · 1978
- Specific binding assay method and reagent means83US 4,205,952 ATechnion Research & Development Foundation Limited · 1980